Biotech

Wise-Owl Initiates Coverage on Nemex Resources (ASX:NXR)

🕔12/4/2014 9:30:20 AM

Nemex Resources Ltd (ASX:NXR) is an Australian company with technology and mineral resource assets. It is presently focused on biometric security through a strategic investment in Wavefront Biometrics Technologies Pty Ltd.

Read Full Article

Rhinomed Limited (ASX:RNO) Mute Granted US FDA Registration

🕔12/3/2014 8:53:39 AM

Melbourne technology firm, Rhinomed (ASX:RNO) is pleased to announce that it has successfully completed the testing and technical documentation that has enabled its new novel snoring and sleep quality product - Mute(TM) to gain acceptance with the US Food and Drug Administration(FDA), European authority (CE Mark) and the Australian Therapeutic Goods Association (TGA).

Read Full Article

Rhinomed Limited's (ASX:RNO) Mute(TM) Successful in Demonstrating Efficacy and Benefit in Snoring Trial

🕔12/2/2014 2:39:58 PM

Melbourne technology firm, Rhinomed (ASX:RNO) today announced the topline results from its independent trial in snoring, sleep quality and night time nasal congestion which successfully demonstrated significant benefit of its new Mute nasal technology. The Company has submitted applications to the European, US and Australian regulatory authorities that will allow sale of the Mute technology to commence.

Read Full Article

Regeneus Ltd (ASX:RGS) New Japanese Laws to Fast Track Cell Therapy Take Effect

🕔11/26/2014 10:07:06 AM

Regeneus Ltd (ASX:RGS) announces that the new Japanese regenerative medicine laws that passed through Parliament in November 2013, have come into effect. These new laws reform the pharmaceutical and medical regulations related to regenerative medicine and provide a rapid approval process specifically designed for regenerative medicine products.

Read Full Article

Regeneus Ltd (ASX:RGS) Concludes Strategic Review and Sets Platform For Next Phase of Development

🕔11/24/2014 9:00:39 AM

Regenerative medicine company, Regeneus Ltd (ASX:RGS), announces that it has completed a strategic review of the business resulting in the company taking a number of measures to streamline its management structure, operations and reduce costs.

Read Full Article

Regeneus Ltd (ASX:RGS) Acne Treatment Patent Granted

🕔11/14/2014 9:23:57 AM

Regenerative medicine company, Regeneus Ltd (ASX:RGS), announces today the granting by the Australian Patent Office of Australian patent number 2013203164. This Regeneus owned patent, Therapeutics for skin conditions, provides protection for the company's stem cell secretions technology for the topical treatment of acne.

Read Full Article

Rhinomed Limited (ASX:RNO) Turbine Achieves CE Mark Registration

🕔11/11/2014 9:16:20 AM

Medical technology company Rhinomed Limited (ASX:RNO) is pleased to announce that it has successfully completed the testing and technical documentation that has enabled its sport technology the Turbine(TM) to receive the CE Mark.

Read Full Article